Forbes
@Forbes
Sign up now for Forbes' free daily newsletter for unmatched insights and exclusive reporting:
参加 November 2009
4.6K フォロー中 20.3M ファン
Shares of biopharmaceutical company Kodiak Sciences Inc. were up more than 150% in the hour after the opening bell Monday morning after promising late-stage trials for a pair of experimental eye drugs that could be the firm’s first products to ever go to market.
Read more:
もっと見る
